Market Research Report Non-Small Cell Lung Cancer Therapeutics Market | Page 4

 Identify commercial opportunities in the NSCLC deals landscape by
analyzing trends in licensing and co-development deals.
Table of Contents:
2 Introduction 11
2.1 Disease Introduction 11
2.2 Epidemiology 12
3 Marketed Products 31
3.1 Overview 31
3.2 Chemotherapies 31
3.2.1 Alimta (pemetrexed) - Eli Lilly 31
4 Pipeline Analysis 50
4.1 Overview 50
4.2 Pipeline by Stage of Development, Molecule Type, Route of Administration and Program
Type 51
4.3 Pipeline by Molecular Target 53
5 Clinical Trial Analysis 79
5.1 Failure Rate 79
5.1.1 Overall Failure Rate 79
6 Multi-scenario Forecast 90
6.1 Overview 90
6.2 Asia-Pacific Market 90
6.3 India 92
7 Drivers and Barriers 106